FDA 483 - University Reproductive Associates, P.C. - January 19, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of University Reproductive Associates, P.C. in Hasbrouck Heights, NJ, a human tissue reproductive establishment, revealed significant deficiencies in donor screening practices. The firm failed to adequately screen oocyte and semen donors for communicable disease risk factors, including West Nile Virus and Zika Virus. Additionally, the facility's written procedures were not designed to ensure compliance with donor eligibility requirements, lacking specific screening protocols for several infectious agents.
ID · 44591c86-2752-482e-85fc-815f1a7a3dc4